<p>Disclosed herein is an ophthalmic formulation comprising a compound of formula (I) wherein R1 is a linear or branched C9-C33 alkyl or a linear or branched C9-C33 alkenyl with 1 to 4 double bonds; R2 is a linear or branched C9-C19 alkyl or a linear or branched C9-C19 alkenyl with 1 to 4 double bonds; and an ophthalmologically acceptable carrier.</p>
申请公布号
WO2013091020(A2)
申请公布日期
2013.06.27
申请号
WO2012AU01595
申请日期
2012.12.21
申请人
UNIVERSITY OF WESTERN SYDNEY;MILLAR, THOMAS;SCHUETT, BURKHARDT
